We are easy to reach.

Phone: (480) 999-5458

Email: info@doctrials.com

Address: Varies by site, click here to find a list of our sites.

Fax Information

Please fax medical documents containing Protected Health Information (PHI) to our HIPAA-compliant fax at (844) 364-1275. These include:

  1. Genetic testing

  2. Lab reports

  3. Blood work

  4. HbA1c Levels

Thank you for helping us protect the privacy of our patients.

We accept faxes that do not contain PHI at our general fax at (480) 999-2991. These include:

  1. Partnerships

  2. Thank you letters

  3. Business inquiries

At DocTrials, eyes are at the heart of everything we do. Happy #WorldSightDay, let’s come together to raise awareness and take a moment to #LoveYourEyes. What did you do today to show your eyes some love? 480-999-5458 #arizona #california #nev
🏖️ Happy National Beach Day! Prolonged sun exposure can lead to pterygium— a growth on the eye’s surface (see second image). To explore our related enrolling trials in California and Arizona, call 805-364-9060 / 480-999-5458 or click on
Join the PROGRESS study team. The PROGRESS study is being done to find out the efficacy of an investigational drug in reducing pain related to diabetic peripheral neuropathy. You may qualify if you’re an adult with ongoing diabetic peripheral n
A clinical research study is looking at an experimental drug for diabetic retinopathy. Are you interested? Call now. 480-999-5458 #clinicalstudies #diabeticretinopathy #retinopathydiabetic #diabeticretinopathyscreening
We’re conducting the PROGRESS study to find out the efficacy of an investigational drug in reducing pain related to diabetic peripheral neuropathy. Adults with diabetes who have ongoing diabetic peripheral neuropathic pain (DPNP) with moderate
Can you believe it’s already August? We’re excited to announce our upcoming studies this month at our Arizona locations: retinal vein occlusion, uveitic macular edema, macular degeneration, and dry eyes. If you or someone you know might b
Diabetic peripheral neuropathic pain (DPNP) affects many people with diabetes. The PROGRESS study is currently exploring the effectiveness of an investigational drug called LX9211 to help treat this condition. LX9211 is a new type of investigational
We’re searching for adults aged over 18 who have diabetic retinopathy to take part in a clinical research study. Contact us. #clinicalresearch #clinicalstudies #clinicaltrials #medicalresearch #researchstudy #diabeticretinopathy #retinopathy
Are you aged 18 to 85 and looking for a possible treatment for your diabetic macular edema (DME)? If so, consider taking part in the DIAMOND-2 Study of an investigational eye drop called OCS-01. To learn more about this clinical research study, pleas
Learn more about the PROGRESS study for adults who have diabetic peripheral neuropathic pain (DPNP) with moderate to severe pain. Learn more: 480-999-5458, email hello@doctrials.com, or apply online by visiting our enrolling studies page linked in ou
LX9211 is a new type of investigational drug being explored for the potential treatment of diabetic peripheral neuropathic pain (DPNP). It is a type of drug called an AP2-associated protein kinase 1 inhibitor (AAK1 inhibitor). It is believed that inh
Our retina research team received a heartwarming surprise— a delightful gift of coffee from Guatemala! The thoughtful note that came with it truly made our day. 🧡 A big shoutout to our dedicated retina research team for their hard work and com

Stay connected with us!

Online Form

If you prefer to submit a form for a non-urgent request, we can do that too!